Correcting the expression of miRNA-155 represses PP2Ac and enhances the release of IL-2 in PBMCs of juvenile SLE patients

Lupus

Volumn 24, Issue 3, 2015, Pages 240-247

  Lashine, Y A ^a   Salah, S ^b   Aboelenein, H R ^a   Abdelaziz, A I ^a  

^a German University in Cairo GUC   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

IL 2; juvenile SLE; MiR 155; PBMCs; PP2Ac

Indexed keywords

AZATHIOPRINE; HYDROXYCHLOROQUINE; INTERLEUKIN 2; MESSENGER RNA; MICRORNA; MICRORNA 155; PHOSPHOPROTEIN PHOSPHATASE 2A; PREDNISONE; MIRN155 MICRORNA, HUMAN; PHOSPHOPROTEIN PHOSPHATASE 2;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVE SITE; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LEUKOCYTE COUNT; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; CASE CONTROL STUDY; CELL CULTURE; CHILD; METABOLISM; MONONUCLEAR CELL; SECRETION (PROCESS);

ARTHRITIS, JUVENILE; CASE-CONTROL STUDIES; CELLS, CULTURED; CHILD; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICRORNAS; PROTEIN PHOSPHATASE 2;

EID: 84922624320     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314552117     Document Type: Article

References (34)

1. Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000 ; 403: 901-906
2. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004 ; 116: 281-297
3. Calame K. MicroRNA-155 function in B cells. Immunity. 2007 ; 27: 825-827
4. O'Connell RM, Kahn D, Gibson WS, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity. 2010 ; 33: 607-619
5. Zhou H, Huang X, Cui H, et al. miR-155 and its star-form partner miR-155∗ cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood. 2010 ; 116: 5885-5894
6. Vigorito E, Perks KL, Abreu-Goodger C, et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity. 2007 ; 27: 847-859
7. O'Connell RM, Chaudhuri AA, Rao DS, Baltimore D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A. 2009 ; 106: 7113-7118
8. Teng G, Hakimpour P, Landgraf P, et al. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity. 2008 ; 28: 621-629
9. Wang G, Tam LS, Li EK, et al. Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol. 2010 ; 37: 2516-2522
10. Wang G, Tam LS, Kwan BC, et al. Expression of miR-146a and miR-155 in the urinary sediment of systemic lupus erythematosus. Clin Rheumatol. 2012 ; 31: 435-440
11. Christen V, Treves S, Duong FH, Heim MH. Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A. Hepatology. 2007 ; 46: 558-565
12. Liu S, Yang Y, Wu J. TNFα-induced up-regulation of miR-155 inhibits adipogenesis by down-regulating early adipogenic transcription factors. Biochem Biophys Res Commun. 2011 ; 414: 618-624
13. Cho US, Xu W. Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme. Nature. 2007 ; 445: 53-57
14. Kranias G, Watt LF, Carpenter H, et al. Protein phosphatase 2A carboxymethylation and regulatory B subunits differentially regulate mast cell degranulation. Cell Signal. 2010 ; 22: 1882-1890
15. Vazquez A, Kulkarni D, Grochola LF, et al. A genetic variant in a PP2A regulatory subunit encoded by the PPP2R2B gene associates with altered breast cancer risk and recurrence. Int J Cancer. 2011 ; 128: 2335-2343
16. Khanna A, Kauko O, Bockelman C, et al. Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells. Cancer Res. 2013 ; 73: 6757-6769
17. Wang X, Blanchard J, Kohlbrenner E, et al. The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment. FASEB J. 2010 ; 24: 4420-4432
18. Crispin JC, Apostolidis SA, Rosetti F, et al. Cutting edge: Protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism. J Immunol. 2012 ; 188: 3567-3571
19. Tan W, Sunahori K, Zhao J, et al. Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. Arthritis Rheum. 2011 ; 63: 2755-2763
20. Katsiari CG, Kyttaris VC, Juang YT, Tsokos GC. Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. J Clin Invest. 2005 ; 115: 3193-3204
21. Cho JH, Kim HO, Kim KS, Yang DH, Surh CD, Sprent J. Unique features of naive CD8+ T cell activation by IL-2. J Immunol. 2013 ; 191: 5559-5573
22. Lord JD, McIntosh BC, Greenberg PD, Nelson BH. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. J Immunol. 2000 ; 164: 2533-2541
23. Almeida AR, Legrand N, Papiernik M, Freitas AA. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers. J Immunol. 2002 ; 169: 4850-4860
24. Melamed A, Cabili S, Zakuth V, Spirer Z. The immune regulation in familial Mediterranean fever (FMF). J Clin Lab Immunol. 1988 ; 26: 125-128
25. Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Horwitz DA. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol. 1983 ; 130: 2651-2655
26. Lu LF, Thai TH, Calado DP, et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity. 2009 ; 30: 80-91
27. Losman JA, Chen XP, Vuong BQ, Fay S, Rothman PB. Protein phosphatase 2A regulates the stability of Pim protein kinases. J Biol Chem. 2003 ; 278: 4800-4805
28. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
29. Yao R, Ma YL, Liang W, et al. MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS One. 2012 ; 7: e46082 - e46082
30. Divekar AA, Dubey S, Gangalum PR, Singh RR. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: An apparent paradox in the setting of an inflammatory milieu. J Immunol. 2011 ; 186: 924-930
31. Murata K, Yoshitomi H, Tanida S, et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther. 2010 ; 12: R86 - R86
32. Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, Chan EK. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther. 2008 ; 10: R101 - R101
33. Buchan G, Barrett K, Fujita T, Taniguchi T, Maini R, Feldmann M. Detection of activated T cell products in the rheumatoid joint using cDNA probes to interleukin-2 (IL-2) IL-2 receptor and IFN-gamma. Clin Exp Immunol. 1988 ; 71: 295-301
34. Richards FM, Milner J, Metcalfe S. Inhibition of the serine/threonine protein phosphatases PP1 and PP2A in lymphocytes: Effect on mRNA levels for interleukin-2, IL-2R alpha, krox-24, p53, hsc70 and cyclophilin. Immunology. 1992 ; 76: 642-647